Published July 7, 2009 | Version Supplemental Material + Published
Journal Article Open

TRPV1-expressing primary afferents generate behavioral responses to pruritogens via multiple mechanisms

  • 1. ROR icon University of California, San Francisco
  • 2. ROR icon University of California, San Diego
  • 3. ROR icon California Institute of Technology

Abstract

The mechanisms that generate itch are poorly understood at both the molecular and cellular levels despite its clinical importance. To explore the peripheral neuronal mechanisms underlying itch, we assessed the behavioral responses (scratching) produced by s.c. injection of various pruritogens in PLCβ3- or TRPV1-deficient mice. We provide evidence that at least 3 different molecular pathways contribute to the transduction of itch responses to different pruritogens: 1) histamine requires the function of both PLCβ3 and the TRPV1 channel; 2) serotonin, or a selective agonist, α-methyl-serotonin (α-Me-5-HT), requires the presence of PLCβ3 but not TRPV1, and 3) endothelin-1 (ET-1) does not require either PLCβ3 or TRPV1. To determine whether the activity of these molecules is represented in a particular subpopulation of sensory neurons, we examined the behavioral consequences of selectively eliminating 2 nonoverlapping subsets of nociceptors. The genetic ablation of MrgprD^+ neurons that represent ≈90% of cutaneous nonpeptidergic neurons did not affect the scratching responses to a number of pruritogens. In contrast, chemical ablation of the central branch of TRPV1+ nociceptors led to a significant behavioral deficit for pruritogens, including α-Me-5-HT and ET-1, that is, the TRPV1-expressing nociceptor was required, whether or not TRPV1 itself was essential. Thus, TRPV1 neurons are equipped with multiple signaling mechanisms that respond to different pruritogens. Some of these require TRPV1 function; others use alternate signal transduction pathways.

Additional Information

© 2009 by the National Academy of Sciences. Contributed by Melvin I. Simon, May 20, 2009 (received for review May 4, 2009). Published online before print June 29, 2009, doi: 10.1073/pnas.0905605106 We thank Mark Zylka for invaluable help, Heeju Kim and Valeria Mancino for help with the behavioral assays, and Timothy M. Kim for video analyses. This work was supported by National Institutes of Health Grant PO1-NS048499 (to M.I.S., D.J.A., and A.I.B.). H.S.L. is supported by an award from the Christopher and Dana Reeve Foundation. D.J.A. is an investigator of the Howard Hughes Medical Institute. Author contributions: A.I.B. and S.-K.H. designed research; N.I., G.H.P., H.L., and S.-K.H. performed research; S.-K.H. analyzed data; and D.J.A., M.I.S., A.I.B., and S.-K.H. wrote the paper. The authors declare no conflict of interest. This article contains supporting information online at www.pnas.org/cgi/content/full/0905605106/DCSupplemental.

Attached Files

Published - Imamachi2009p5070P_Natl_Acad_Sci_Usa.pdf

Supplemental Material - 0905605106SI.pdf

Files

0905605106SI.pdf

Files (1.3 MB)

Name Size Download all
md5:dbb9a2415952094079cefb890c8ca1a0
272.7 kB Preview Download
md5:0b32e86073d31c4b4f683886f59aba39
1.1 MB Preview Download

Additional details

Identifiers

PMCID
PMC2708751
Eprint ID
15203
Resolver ID
CaltechAUTHORS:20090820-164722093

Funding

NIH
PO1-NS048499
Christopher and Dana Reeve Foundation
Howard Hughes Medical Institute (HHMI)

Dates

Created
2009-09-08
Created from EPrint's datestamp field
Updated
2021-11-08
Created from EPrint's last_modified field